NCT01426035撤回3 期
Phase III of Safety and Efficacy Study of Topic Mucopolysaccharide Polysulfate Cream 5mg/g in the Superficial Varicose Veins Treatment
EMS1 个研究点 分布在 1 个国家开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 发起方
- 试验地点
- 1
- 主要终点
- Efficacy - Symptoms reduction
研究概览
简要总结
Evaluate the safety, tolerability and effectiveness of mucopolysaccharide polysulfate cream in the treatment of superficial varicose veins
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must be able to understand the study procedures, agree to participate, and give written consent.
- •Patients must be able to follow the study medication regimen.
- •Patients with inflammatory process in superficial veins for more than 72 hours.
- •Presence of symmetric lesions to compare one side to the other.
排除标准
- •Pregnancy or risk of pregnancy.
- •Lactation.
- •Use of topical or systemic anti-inflammatory, antihistamine or immunosuppressive drugs within the last 48 hours prior to the study
- •Any alteration at other deep veins.
- •History of atopy or allergic diseases.
- •History of allergy to any component of the formulations.
- •Other conditions considered by the investigator as reasonable for non-eligibility
研究组 & 干预措施
GROUP 1
Experimental
干预措施: TOPIC MUCOPOLYSACCHARIDE POLYSULFATE CREAM 5MG/G (Drug)
GROUP 2
Active Comparator
干预措施: TOPIC MUCOPOLYSACCHARIDE POLYSULFATE CREAM 5MG/G (Drug)
结局指标
主要结局
Efficacy - Symptoms reduction
时间窗: Evaluation time: 15 days treatment
The primary outcome measure will be evaluated for: Lesion area reduction, reduction of symptoms time and edema
次要结局
- Efficacy - patient evaluation(Evaluation time: 15 days treatment)
研究者
研究点 (1)
Loading locations...
相似试验
撤回
3 期
Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate In The Superficial Varicose Veins TreatmentVARICOSE VEINSNCT01203397EMS
招募中
2 期
Radiation Cystitis Treated With Pentosan Polysulfate Sodium TrialRadiation CystitisNCT05245591National Taiwan University Hospital72
已完成
3 期
Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal SurgeryInfectionsNCT01297959Excited States, LLC503
进行中（未招募）
2 期
A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)Squamous Cell CarcinomaNCT06041802Merck Sharp & Dohme LLC19
已完成
3 期
Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary AngioedemaHereditary Angioedema (HAE)NCT02584959Shire75